FDA to assess AstraZeneca’s at-home nasal flu shot … Study: Older Black people more likely get low-value diagnostic tests compared to whites, but older whites get worse screening tests, treatments...
A first? COVID antibody therapy with full-year protection is up for FDA authorization
By
Alicia Lasek
Oct 08, 2021
Drugmaker AstraZeneca has asked the FDA to authorize what it says could be the first long-acting monoclonal antibody drug therapy for the prevention of COVID-19 in at-risk patients.
Diabetes med Farxiga gets FDA nod as kidney failure treatment; drug cuts risk by 39 percent
By
Alicia Lasek
May 04, 2021
Farxiga, an SGLT2 inhibitor, was found to reduce the risk of worsening renal function or cardiovascular or renal death by 39% in patients with chronic kidney disease — with and without type 2 diabetes.
Makers of newer vaccines tout advantages as trial results and approvals announced
By
Alicia Lasek
Feb 01, 2021
Two drugmakers say their vaccines, which include J&J’s one-dose candidate, are effective against new coronavirus variants, while AstraZeneca’s vaccine is now approved for adults across the...
Clinical briefs for Monday, Dec. 7
By
Alicia Lasek
Dec 07, 2020
Researchers urge priority vaccination for individuals with diabetes … AstraZeneca vaccine approval iffy in U.S. with current data, OWS scientist says … WHO trial finds no benefit of 4 drugs for hospitalized...
The vaccine was most protective — at 90% efficacy — when participants received an initial half dose and then a full dose a month apart, the U.K. drugmaker says.
AstraZeneca’s coronavirus vaccine triggers immune response in older people
By
Alicia Lasek
Nov 20, 2020
The experimental vaccine was safe and well-tolerated among all 560 trial participants, including adults aged 70 and older, the company said Thursday.
AstraZeneca’s COVID vaccine boosts immune response in older adults
By
Alicia Lasek
Oct 27, 2020
The experimental vaccine also reduced the risk of adverse events in older study participants, the drugmaker reports.
Feds race to buy COVID antibody cocktails
By
Alicia Lasek
Oct 14, 2020
The federal government is planning to stockpile COVID-19 antibody drugs in an effort to ensure treatment availability while the country awaits a vaccine.
Clinical briefs for Tuesday, Sept. 15
By
Alicia Lasek
Sep 15, 2020
AstraZeneca COVID vaccine trial on hold in U.S. despite resuming elsewhere … Collapsed lung a complication of COVID-19; specialist care needed for older men … Pfizer, BioNTech enlarge late-stage coronavirus...